SecBot SecBot
8-K ·Filed Jul 21, 2026

ASPI

ASP Isotopes Inc.
NEUTRAL
Impact 3/10
Horizonmonths Processed3mo ago SEC0001193125-26-309573
8-K context-dependent: Items 7.01
Actionable Insight • Neutral

This is a routine FD disclosure of a research collaboration with no immediate financial impact. Monitor for future milestones such as pilot-scale results or regulatory approvals, but no near-term catalyst is present.

DirectionNeutral
Confidencehigh
Horizonmonths
Final — all horizons settled through T+60d ⚠ clustered
ASPI ▼ -46.48% at T+60d
NEUTRAL call -46.48% · α vs SPY -50.45% · entry $4.26 → $2.28
Entry = T+0 close
Jul 21, 2026
via day close
T+1d
-4.23%
call -4.23% · α -4.11%
$4.08
settled 3mo ago
T+5d
-4.93%
call -4.93% · α -3.70%
$4.05
settled 3mo ago
T+20d
-9.39%
call -9.39% · α -11.95%
$3.86
settled 2mo ago
T+60d
-46.48%
call -46.48% · α -50.45%
$2.28
settled 12d ago

Price Chart

Loading chart...

Executive Summary

ASP Isotopes announced a research agreement between its subsidiary Quantum Leap Energy and Texas A&M Engineering Experiment Station to advance commercial production of high-purity uranium hexafluoride (UF6), a critical nuclear fuel feedstock. The agreement focuses on collecting physicochemical data to improve conversion efficiency and scalability, but no financial terms or near-term revenue impact were disclosed.

Key Facts

  • QLE signed a research agreement with TEES to de-risk commercial UF6 production from yellowcake (U3O8).
  • The U.S. currently has only one operating commercial uranium conversion facility.
  • No financial terms, revenue guidance, or material financial data were disclosed in the filing.
  • QLE is a development-stage subsidiary; the company has not yet applied its enrichment technologies to U-235 except under a Necsa contract.

Financial Impact

Not specified

Risk Factors

  • Development-stage company with no revenue from this agreement.
  • Technical and regulatory risks in uranium conversion and enrichment.
  • Forward-looking statements subject to uncertainties; no guarantee of commercialization.

Market Snapshot

Exchange
Nasdaq
Sector
Miscellaneous Chemical Products
Analyst Consensus
89% bullish (9 analysts)

Investment Themes

Materials & Mining

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-309573
Document: aspi-ex99_1.htm0001193125-26-309573
Document: 0001193125-26-309573-index-headers.html0001193125-26-309573
Document: 0001193125-26-309573-index.html0001193125-26-309573
Document: 0001193125-26-309573.txt0001193125-26-309573
31 reports for ASPI
Performance horizon
56% Hit rate @ T+5 5 of 9 directional calls Went positive at some point 8 of 9 best @ T+60▲ +37.03%Jul 16, 2026
Filters
Rows
Reports for ASPI — sortable, filterable
TypeNow
Oct 26, 2026
today
8-K
NEUTRAL ★ 4/10
$2.07awaiting T+5—$2.03 (−2.18%)
Oct 15, 2026
11d ago
8-K
BULLISH ★ 6/10
$2.21 $2.09▼ −5.43%▼ −4.42%$2.03 (−8.34%)
Oct 2, 2026
24d ago
8-K
NEUTRAL ★ 3/10
$2.91 $2.65▼ −8.93%▼ −10.10%$2.03 (−30.39%)
Sep 25, 2026
4w ago
144
NEUTRAL ★ 2/10
$2.60 $2.93▲ +12.69%▲ +11.49%$2.03 (−22.09%)
Sep 9, 2026
6w ago
425
NEUTRAL ★ 5/10
$3.82 $3.15▼ −17.54%▼ −16.44%$2.03 (−46.97%)
Sep 2, 2026
7w ago
144
NEUTRAL ★ 3/10
$3.90 $3.31▼ −15.13%▼ −13.98%$2.03 (−48.06%)
Aug 20, 2026
9w ago
425 / 8-K
BULLISH ★ 6/10
$3.95 $4.04▲ +2.41%▲ +1.29%$2.03 (−48.65%)
Aug 18, 2026
9w ago
8-K
NEUTRAL ★ 3/10
$3.86 $4.00▲ +3.63%▲ +3.83%$2.03 (−47.52%)
Aug 16, 2026
10w ago
Institutional Cluster
MIXED ★ 4/10
$4.02 $3.89▼ −3.23%▼ −2.04%$2.03 (−49.61%)
Aug 5, 2026
11w ago
425
NEUTRAL ★ 3/10
$4.10 $4.28▲ +4.39%▲ +3.18%$2.03 (−50.60%)
Showing 10 of 31

US Market Status

Market Open — Closes in 5h 16m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 21, 2026